Reckitt Benckiser shares gain about 1.5% after announcing major share buyback programme

Traders Union
All News
Stocks
Reckitt benckiser rises 1.52% today

Highlights

Reckitt Benckiser has launched a £500 million share buyback program over 12 months, with an initial £150 million tranche beginning August 5, 2026.
Subsidiary Mead Johnson Nutrition Company has announced a cash tender offer for $500 million of 4.6% Senior Notes due 2044.
Reckitt Benckiser stock displays bullish momentum with a 70% probability of trading higher, expected to range between GBX5,253 and GBX5,451 in the next five sessions.

Buyback start, debt tender, and dividend create active capital flows

Reckitt Benckiser has initiated a share buyback programme of up to £500 million over 12 months, with an initial tranche of up to £150 million beginning on August 5, 2026. The buyback will be managed by Citigroup Global Markets Limited and shares purchased will be held in treasury. Additionally, subsidiary Mead Johnson Nutrition Company launched a cash tender offer for outstanding $500 million 4.600% Senior Notes due 2044, and the company has an upcoming ex-dividend date of August 6 with a dividend of 0.886 GBX per share.

Anton Kharitonov, expert at Traders Union, sees short-term buying interest after the buyback announcement, but he remains skeptical about the long-term sustainability. He notes that Reckitt Benckiser trades below its 200-day average, signalling persistent structural weakness. Technical indicators do show buying strength, but several hint at overbought conditions. He is cautious about the sideways corridor and sees risk if GBX5,302 support is breached. "Fundamental drivers like the tender offer may attract temporary demand, but I would not overstate bullish momentum while the 200-day moving average still blocks further upside."

Viktoras Karapetjanc, expert at Traders Union, highlights the constructive impact of the £500 million buyback on shareholder value and sentiment. He views the news as supporting a bullish medium-term structure, with the tender offer and dividend enhancing confidence in sustained capital returns. For Karapetjanc, macro conditions remain supportive, and the market offers strong setups as Reckitt Benckiser trades above its near-term moving averages. "Further growth and positive flows can be expected as management signals clear commitment to capital efficiency and shareholder rewards."

Parshwa Turakhiya, analyst, believes the buyback-driven rally is stirring positive sentiment, especially as short-term technicals turn bullish. He notes that the oscillation between GBX5,302 and GBX5,354 creates tradable volatility for nimble participants. Turakhiya points out that momentum indicators look strong, but the overbought readings suggest fast shifts are likely. "With buyers still holding the reins, I see actionable opportunity within these tight bands — but I’d watch for swift mean reversion on any momentum fade."

Short- to medium-term bullish momentum meets overbought signals at resistance

Reckitt Benckiser is trading above its 20-day and 50-day moving averages (GBX5,093 and GBX4,871), underscoring short- and medium-term strength, but remains below the 200-day moving average at GBX5,548, pointing to lingering long-term pressure. Immediate support and resistance are set at the near-term floor of GBX5,302 and the ceiling at GBX5,354. Momentum signals are constructive, with the MACD and ADX both registering buy signals and the RSI at 61.41 with a buy outlook. However, the CCI and BBP warn of overbought conditions as buyers dominate intraday momentum. The Awesome Oscillator supports the positive trend, while the Stochastic RSI is neutral, providing a slight counterpoint to strong momentum.

Previously it was reported that analysts expected Reckitt Benckiser to trade in a sideways range, underpinned by share buyback and debt reduction initiatives, but constrained by technical resistance. The current analysis strengthens this outlook, highlighting a further build-up in upward momentum and identifying GBX5,354 as a key resistance level to monitor for a potential breakout in the near term.

Source of Data: RKT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.